Literature DB >> 4026570

Reduction and binding of arsenate in marmoset monkeys.

M Vahter, E Marafante.   

Abstract

The metabolism of 74As-arsenate (As V, 0.4 mg As/kg body weight, IV) in marmoset monkeys (two males and two females) was studied. Unlike all other animal species studied so far, the marmoset was found to be unable to metabolize the arsenate to dimethylarsinic acid. Most of the absorbed arsenate was reduced to arsenite (As III) in vivo. Only 20% was excreted in the urine as unchanged As V. A further 20% of the dose was excreted as As III. The rest of the As III produced was bound to the tissues, giving a distribution picture very similar to that reported earlier for marmoset monkeys given arsenite. The tissues with longest retention of arsenic were the liver, upper gastrointestinal tract (oral cavity and esophagus), skin, kidneys and gall bladder. The pronounced accumulation in the liver resulted from specific binding of arsenic to the rough microsomal membranes, unique to this animal species.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026570     DOI: 10.1007/bf00343121

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  25 in total

1.  The metabolism of arsenic in laboratory animals using As74 as a tracer.

Authors:  H LANZ; P C WALLACE; J G HAMILTON
Journal:  Univ Calif Publ Pharmacol       Date:  1950

2.  Whole-body retention, excretion and metabolism of [74As]arsenic acid in the hamster.

Authors:  S M Charbonneau; J G Hollins; G K Tam; F Bryce; J M Ridgeway; R F Willes
Journal:  Toxicol Lett       Date:  1980-03       Impact factor: 4.372

3.  Tissue distribution and retention of 74As-dimethylarsinic acid in mice and rats.

Authors:  M Vahter; E Marafante; L Dencker
Journal:  Arch Environ Contam Toxicol       Date:  1984-05       Impact factor: 2.804

4.  Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats.

Authors:  M Vahter
Journal:  Environ Res       Date:  1981-08       Impact factor: 6.498

5.  Metabolism of 74As-labeled trivalent and pentavalent inorganic arsenic in mice.

Authors:  M Vahter; H Norin
Journal:  Environ Res       Date:  1980-04       Impact factor: 6.498

6.  Human retention studies with 74As.

Authors:  C Pomroy; S M Charbonneau; R S McCullough; G K Tam
Journal:  Toxicol Appl Pharmacol       Date:  1980-05       Impact factor: 4.219

7.  Metabolism of inorganic arsenic (74As) in humans following oral ingestion.

Authors:  G K Tam; S M Charbonneau; F Bryce; C Pomroy; E Sandi
Journal:  Toxicol Appl Pharmacol       Date:  1979-09-15       Impact factor: 4.219

8.  In vivo reduction of arsenate in mice and rabbits.

Authors:  M Vahter; J Envall
Journal:  Environ Res       Date:  1983-10       Impact factor: 6.498

9.  Reduction and methylation of sodium arsenate in the rat.

Authors:  I R Rowland; M J Davies
Journal:  J Appl Toxicol       Date:  1982-12       Impact factor: 3.446

10.  Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man.

Authors:  J P Buchet; R Lauwerys; H Roels
Journal:  Int Arch Occup Environ Health       Date:  1981       Impact factor: 3.015

View more
  17 in total

1.  Dimethylarsenic acid induces tetraploids in Chinese hamster cells.

Authors:  G Endo; K Kuroda; A Okamoto; S Horiguchi
Journal:  Bull Environ Contam Toxicol       Date:  1992-01       Impact factor: 2.151

2.  Carcinogenic risks of inorganic arsenic in perspective.

Authors:  D M Byrd; M L Roegner; J C Griffiths; S H Lamm; K S Grumski; R Wilson; S Lai
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

3.  Interspecies differences in metabolism of arsenic by cultured primary hepatocytes.

Authors:  Zuzana Drobná; Felecia S Walton; Anne W Harmon; David J Thomas; Miroslav Stýblo
Journal:  Toxicol Appl Pharmacol       Date:  2010-02-04       Impact factor: 4.219

4.  Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate.

Authors:  Zuzana Drobna; Hua Naranmandura; Kevin M Kubachka; Brenda C Edwards; Karen Herbin-Davis; Miroslav Styblo; X Chris Le; John T Creed; Noboyu Maeda; Michael F Hughes; David J Thomas
Journal:  Chem Res Toxicol       Date:  2009-10       Impact factor: 3.739

5.  Metabolism and disposition of inorganic arsenic in laboratory animals and humans.

Authors:  J D McKinney
Journal:  Environ Geochem Health       Date:  1992-06       Impact factor: 4.609

6.  Pharmacokinetic modeling of arsenite uptake and metabolism in hepatocytes--mechanistic insights and implications for further experiments.

Authors:  Michael R Easterling; Miroslav Styblo; Marina V Evans; Elaina M Kenyon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-06       Impact factor: 2.745

7.  Airborne arsenic and urinary excretion of metabolites of inorganic arsenic among smelter workers.

Authors:  M Vahter; L Friberg; B Rahnster; A Nygren; P Nolinder
Journal:  Int Arch Occup Environ Health       Date:  1986       Impact factor: 3.015

Review 8.  High arsenic groundwater: mobilization, metabolism and mitigation--an overview in the Bengal Delta Plain.

Authors:  Rupa Bhattacharyya; Debashis Chatterjee; Bibhash Nath; Joydev Jana; Gunnar Jacks; Marie Vahter
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

9.  Intracellular distribution and chemical forms of arsenic in rabbits exposed to arsenate.

Authors:  M Vahter; E Marafante
Journal:  Biol Trace Elem Res       Date:  1989 Jul-Sep       Impact factor: 3.738

10.  Arsenic biotransformation as a cancer promoting factor by inducing DNA damage and disruption of repair mechanisms.

Authors:  Victor D Martinez; Emily A Vucic; Marta Adonis; Lionel Gil; Wan L Lam
Journal:  Mol Biol Int       Date:  2011-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.